Connecting you to content on EBSCOhost

Works matching IS 11732563 AND DT 2011 AND VI 31 AND IP 3

Results: 6

1

Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 201, doi. 10.2165/11587590-000000000-00000
Publication type:: Article

2

Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 191, doi. 10.2165/11538910-000000000-00000
Publication type:: Article

3

Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 181, doi. 10.2165/11586330-000000000-00000
Publication type:: Article

4

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 169, doi. 10.2165/11538700-000000000-00000
Publication type:: Article

5

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 155, doi. 10.2165/11586630-000000000-00000
Publication type:: Article

6

Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone.

Published in:: Clinical Drug Investigation, 2011, v. 31, n. 3, p. 143, doi. 10.2165/11539950-000000000-00000
Publication type:: Article